ArticleThe oncologist2026

Phase I trial of binimetinib plus hydroxychloroquine in patients with previously treated metastatic pancreatic cancer.

S Daniel Haldar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.